ORGANIC
LETTERS
2007
Vol. 9, No. 18
3683-3685
Chemoenzymatic Approaches to
Lycorine-Type Amaryllidaceae
Alkaloids: Total Syntheses of
ent-Lycoricidine, 3-epi-ent-Lycoricidine,
and 4-Deoxy-3-epi-ent-lycoricidine
Maria Matveenko, Okanya J. Kokas, Martin G. Banwell,* and Anthony C. Willis
Research School of Chemistry, Institute of AdVanced Studies, The Australian National
UniVersity, Canberra, ACT 0200, Australia
Received July 2, 2007
ABSTRACT
The readily available and enzymatically derived cis-1,2-dihydrocatechol 4 has been elaborated, over 11 steps including an Overman rearrangement,
into the non-natural enantiomer, (
−
)-1, of the alkaloid lycoricidine [(
+
)-1]. Related chemistries have provided analogues 18, 19, and 26.
The lycorine-type Amaryllidaceae alkaloids (+)-lycoricidine
[(+)-1], (+)-narciclasine [(+)-2], and (+)-pancratistatin [(+)-
3] have been known for many years and have been isolated
from, inter alia, plants of the genus Amaryllidaceae including
the bulbs of narcissi and daffodils.1 The potent biological
properties of such compounds, particularly their carcinostatic
and antiviral qualities, have resulted in their being considered
for use as therapeutic agents.2 For example, (+)-pancratistatin
and some of its derivatives have been the subject of
preclinical development studies as agents for the treatment
of certain cancers.2 This situation, together with the limited
availability of certain of these alkaloids from natural sources,
has prompted a substantial body of work directed at the
development of practical synthetic routes to these compounds
and various analogues. The extensive efforts devoted to this
matter have been the subject of a number of recent reviews.3
Work in the area continues unabated.4
As part of a continuing program to exploit readily
available, microbially derived and enantiomerically pure cis-
1,2-dihydrocatechols such as 4 as starting materials in
chemical synthesis,5 we have developed and now report
efficient synthetic sequences that enable the rather rapid
(1) For reviews dealing with this class of alkaloid, see: (a) Martin, S.
F. In The Alkaloids; Brossi, A., Ed.; Academic Press: San Diego, 1987;
Vol. 30, p 251. (b) Hoshino, O. In The Alkaloids; Cordell, G. A., Ed.;
Academic Press: San Diego, 1998; Vol. 51, p 323. (c) Jin, Z. Nat. Prod.
Rep. 2003, 20, 606.
(2) For useful points on entry into the literature concerned with the
biological properties of lycorine-type alkaloids and their analogues, see:
(a) Pettit, G. R.; Melody, N. J. Nat. Prod. 2005, 68, 207. (b) McNulty, J.;
Larichev, V.; Pandey, S. Bioorg. Med. Chem. Lett. 2005, 15, 5315. (c) Pettit,
G. R.; Eastham, S. A.; Melody, N.; Orr, B.; Herald, D. L.; McGregor, J.;
Knight, J. C.; Doubek, D. L.; Pettit, G. R., III; Garner, L. C.; Bell, J. A. J.
Nat. Prod. 2006, 69, 7.
(3) (a) Hudlicky, T. J. Heterocycl. Chem. 2000, 37, 535. (b) Rinner, U.;
Hudlicky, T. Synlett 2005, 365. (c) Chapleur, Y.; Chre´tien, F.; Ibn Ahmed,
S.; Khaldi, M. Curr. Org. Synth. 2006, 3, 341.
(4) For recent synthetic efforts in this area that have not been covered
in the above-mentioned reviews,3 see: (a) Zhang, H.; Padwa, A. Synlett
2006, 2317. (b) Zhang, H.; Padwa, A. Org. Lett. 2006, 8, 247. (c) Shukla,
K. H.; Boehmler, D. J.; Bogacyzk, S.; Duvall, B. R.; Peterson, W. A.;
McElroy, W. T.; DeShong, P. Org. Lett. 2006, 8, 4183. (d) Li, M.; Wu, A.;
Zhou, P. Tetrahedron Lett. 2006, 47, 3707. (e) Crich, D.; Krishnamurthy,
V. Tetrahedron 2006, 62, 6830. (f) Shin, I.-J.; Choi, E.-S.; Cho, C.-G.
Angew. Chem., Int. Ed. 2007, 46, 2303. (g) Padwa, A.; Zhang, H. J. Org.
Chem. 2007, 72, 2570.
10.1021/ol701552r CCC: $37.00
© 2007 American Chemical Society
Published on Web 08/08/2007